NCT03176693View on ClinicalTrials.gov

Preoperative Alpha Blockade for Pheochromocytoma

PHASE3CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

January 31, 2020

Study Completion Date

October 10, 2021

Conditions
PheochromocytomaParaganglioma
Interventions
DRUG

Phenoxybenzamine

Non-selective alpha blocker

DRUG

Doxazosin

Selective alpha blocker

Trial Locations (1)

90025

University of California, Los angeles, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT03176693 - Preoperative Alpha Blockade for Pheochromocytoma | Biotech Hunter | Biotech Hunter